0 Canadian Stock Exchange News - January 5, 2024Class 1 Nickel and Technologies Ltd. Announces Private PlacementTORONTO, Jan. 05, 2024 (GLOBE NEWSWIRE) — Class 1 Nickel and Technologies Ltd. (CSE: NICO/OTCQB: NICLF) (“Class 1 Nickel” or […]Read More
0 NASDAQ Companies - January 5, 2024StoneCo Announces SCFI LicenseGEORGETOWN, Cayman Islands, Jan. 05, 2024 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE; B3: STOC31) (“Stone” or the “Company”) today […]Read More
0 TSX News - January 5, 2024Stingray and BYD Expand Partnership to Include Calm Radio in their EV CarsMONTREAL, Jan. 05, 2024 (GLOBE NEWSWIRE) — Stingray (TSX: RAY.A; RAY.B), a leading music, media, and technology company, today announced […]Read More
0 NASDAQ Companies - January 5, 2024Amesite Offering Teacher Training on AI Technology in new Contract with Scottsdale Unified School DistrictDETROIT, Jan. 05, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based […]Read More
0 NASDAQ Companies - January 5, 2024German American Bank named a Best Bank 2024 by NewsweekJASPER, Ind., Jan. 05, 2024 (GLOBE NEWSWIRE) — German American Bank recently received recognition by Newsweek as one of America’s […]Read More
0 NASDAQ Companies - January 5, 2024Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company […]Read More
0 NASDAQ Companies - January 5, 2024OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024LONDON and NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing […]Read More
0 NASDAQ Companies - January 5, 2024Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in ProceedsMIAMI, Jan. 05, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company […]Read More
0 NASDAQ Companies - January 5, 2024Cassava Sciences Completes Dividend Distribution of Warrants to ShareholdersShareholders of Record Received Warrants to Purchase Shares of Common Stock Warrants Trade on Nasdaq Under the Ticker “SAVAW” Warrant […]Read More
0 NASDAQ Companies - January 5, 2024Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell MalignanciesSEATTLE, Jan. 05, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for […]Read More